Get started
Incyte CorporationIncyte CorporationIncyte Corporation

Incyte Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

INCY chart


Full chart

INCY upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪13.45 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
494.62
Basic EPS (TTM)
0.17 USD
Net income (FY)
‪597.60 M‬ USD
Revenue (FY)
‪3.70 B‬ USD
Shares float
‪189.56 M‬
Beta (1Y)
0.73

Employees


Employees (FY)
‪2.52 K‬
Change (1Y)
+200 +8.61%
Revenue / Employee (1Y)
‪1.46 M‬ USD
Net income / Employee (1Y)
‪236.77 K‬ USD

About Incyte Corporation


Sector
Health Technology
CEO
Herve Hoppenot
Headquarters
Wilmington
Website
incyte.com
Founded
1991
FIGI
BBG000BNPSQ9
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

INCY news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Sparks


Curated watchlists where INCY is featured.

See all sparks 

Frequently Asked Questions


The current price of INCY is 69.91 USD — it has increased by 0.10% in the past 24 hours. Watch Incyte Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Incyte Corporation stocks are traded under the ticker INCY.
INCY stock has risen by 1.64% compared to the previous week, the month change is a −0.74% fall, over the last year Incyte Corporation has showed a 12.90% increase.
We've gathered analysts' opinions on Incyte Corporation future price: according to them, INCY price has a max estimate of 100.00 USD and a min estimate of 52.00 USD. Watch INCY chart and read a more detailed Incyte Corporation stock forecast: see what analysts think of Incyte Corporation and suggest that you do with its stocks.
INCY reached its all-time high on Mar 15, 2017 with the price of 153.15 USD, and its all-time low was 1.66 USD and was reached on Sep 22, 1994. View more price dynamics on INCY chart.
See other stocks reaching their highest and lowest prices.
INCY stock is 1.71% volatile and has beta coefficient of 0.73. Track Incyte Corporation stock price on the chart and check out the list of the most volatile stocks — is Incyte Corporation there?
Today Incyte Corporation has the market capitalization of ‪13.45 B‬, it has decreased by −4.26% over the last week.
Yes, you can track Incyte Corporation financials in yearly and quarterly reports right on TradingView.
Incyte Corporation is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
INCY earnings for the last quarter are 1.07 USD per share, whereas the estimation was 1.05 USD resulting in a 1.79% surprise. The estimated earnings for the next quarter are 1.51 USD per share. See more details about Incyte Corporation earnings.
Incyte Corporation revenue for the last quarter amounts to ‪1.14 B‬ USD, despite the estimated figure of ‪1.08 B‬ USD. In the next quarter, revenue is expected to reach ‪1.14 B‬ USD.
INCY net income for the last quarter is ‪106.46 M‬ USD, while the quarter before that showed ‪−444.60 M‬ USD of net income which accounts for 123.94% change. Track more Incyte Corporation financial stats to get the full picture.
No, INCY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has ‪2.52 K‬ employees. See our rating of the largest employees — is Incyte Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Incyte Corporation EBITDA is ‪76.18 M‬ USD, and current EBITDA margin is 19.87%. See more stats in Incyte Corporation financial statements.
Like other stocks, INCY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Incyte Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Incyte Corporation technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Incyte Corporation stock shows the neutral signal. See more of Incyte Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.